Alibaba Health Information Technology Limited
0241.HK

$7.32 B
Marketcap
$0.46
Share price
Country
$-0.03
Change (1 day)
$0.81
Year High
$0.33
Year Low

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.

marketcap

P/B ratio for Alibaba Health Information Technology Limited (0241.HK)

P/B ratio as of 2023: 2.75

According to Alibaba Health Information Technology Limited's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.75. At the end of 2022 the company had a P/B ratio of 4.42.

P/B ratio history for Alibaba Health Information Technology Limited from 2003 to 2023

P/B ratio at the end of each year

Year P/B ratio
2023 2.75
2022 4.42
2021 3.93
2020 17.17
2019 26.80
2018 29.78
2017 11.10
2016 21.52
2015 26.32
2014 31.92
2013 46.70
2012 4.51
2011 4.47
2010 10.32
2009 15.44
2008 1.09
2007 3.09
2006 9.37
2005 10.91
2004 37.45
2003 14.88